Document is current
Any future updates will be listed below
-
Authors
Kaplan, Gilaad G. https://orcid.org/0000-0003-2719-0556
- License Information
-
More Information
Article History
Accepted: 17 June 2025
First Online: 18 July 2025
Competing interests
: G.G.K. has received honoraria for speaking or consultancy from AbbVie, Amgen, Janssen, Pfizer and Takeda; and has received grants for research from Ferring and for educational activities from AbbVie, Bristol Myers Squibb, Ferring, Fresenius-Kabi, Janssen, Pfizer and Takeda. He shares ownership of a patent: Use of mirtazapine in the treatment of inflammatory disorders, autoimmune disease and PBC (patent WO/2019/046959A1, PCT/CA2018/051098).
